CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation
Osteolytic bone disease is a hallmark of multiple myeloma (MM). A significant fraction (~20%) of MM patients do not develop osteolytic lesions (OLs). The molecular basis for the absence of bone disease in MM is not understood. We combined PET-CT and gene expression profiling (GEP) of purified BM CD1...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Clinical Investigation
2022-09-01
|
| Serier: | The Journal of Clinical Investigation |
| Fag: | |
| Online adgang: | https://doi.org/10.1172/JCI159527 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
